سعر هيموهيس 6% محلول 2022

Hydroxyethyl starch 6% solution for intravenous infusion (Hemohes, B. Braun; marketed by Sunny Medical), a colloidal plasma volume expander.

• Treatment of hypovolaemia due to acute blood loss when crystalloids alone are not considered sufficient (EU-restricted use for HES solutions)European Medicines Agency

• Must no longer be used in patients with sepsis, burn injuries or critical illness (increased risk of kidney injury and mortality). Contraindicated in renal impairment or renal replacement therapy and in severe coagulopathy.General active-ingredient information · European Medicines Agency

• Use only for hypovolaemia due to acute blood loss when crystalloids alone are insufficient; lowest effective dose for the shortest time (not more than 24 hours), guided by continuous haemodynamic monitoring. Discontinue at the first sign of renal injury or coagulopathy; increased need for renal replacement therapy reported up to 90 days after administration. Lack of robust long-term safety data in surgery and trauma.General active-ingredient information · European Medicines Agency
• In January 2018 EMA's PRAC recommended suspending marketing authorisations of HES infusion solutions (news item on the referral page).General active-ingredient information · European Medicines Agency

English text not available for this section.